Diagnostics Solutions Strategic Priorities slide image

Diagnostics Solutions Strategic Priorities

Roche Cardiovascular disease solutions New solutions to impact medical practice Coronary artery disease >>> Launch new intended uses in 2021 TnT-hs in non-cardiac surgeries. Diagnosis of peri-operative myocardial infarction (MI) TnT-hs in asymptomatic population. Long- term risk stratification of cardiovascular events New patient population 300 million surgeries 1.2 457 million at age 70+ Heart failure >>> Heart Failure prevention in diabetes. Identify patients at high CV risk and start protective therapy 463 million with diabetes³ Stroke prevention in atrial fibrillation >>> NT-proBNP + ECG for atrial fibrillation screening in the elderly 457 million at age 70+ 1 Puelacher C et al. Circulation. 2018;137:1221; 2 Devereaux PJ et al. JAMA 2017;317:1642; 3 Saeedi P et al., Diabetes Res Clin Pract 2019: 4 World Data Atlas. https://knoema.com/atlas/topics/Demographics/Age/Population-aged-70-years 60
View entire presentation